World Of Taxonomy
71287-220Level 3

TECARTUS (brexucabtagene autoleucel)

**Product type:** Cellular Therapy

**Active ingredient:** BREXUCABTAGENE AUTOLEUCEL

**Strength:** 1000000 1/68mL

**Dosage form:** Suspension

**Route:** Intravenous

**Labeler:** Kite Pharma, Inc.

**Marketing category:** BLA (BLA125703)

GET/api/v1/systems/ndc_fda/nodes/71287-220
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.